The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.

Total artificial heart recipients typically stay in the hospital. In this case, however, the patient was able to wait for a donated heart from the comfort of his own home.

TAVR adoption in Africa has been relatively slow, but cardiologists throughout the continent have made considerable progress. New data does show that there is some work to be done before outcomes will rival what is seen in many other parts of the world.

Researchers explored data from nearly 80,000 patients, comparing the newest clot-busting stroke drug from Genetech with its predecessor.

Multiple women have come forward with similar allegations against the Texas cardiologist. Police believe there may be additional victims as well.

CDC data shows that mortality from heart failure-related cardiac arrest has decreased significantly in the last 25 years. However, researchers noted, care teams still have considerable work to do.

The Outsourcing Facilities Association, a Texas-based trade group, is alleging that supply issues still remain for Ozempic and Wegovy. The group believes the FDA has ignored those issues.

The acquisition helps Teleflex expand its interventional and vascular portfolios. Biotronik, meanwhile, is shifting its focus toward implantable devices and digital healthcare. 

Google worked with AI specialists, cardiologists and even stunt performers to develop its new smartwatch feature.

ECRI compiled its latest list of healthcare hazards based on a wide scope of data, hoping to pintpoint the most pressing threats to patients' well-being. 

Over a year after the breach on Change Healthcare, CareFirst BlueCross BlueShield of Maryland has filed a lawsuit saying it suffered data loss stemming from the incident.